2-aminoquinazolines as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
US-12570640-B2 · Mar 10, 2026 · US
This page is not indexed by search engines while we improve data quality.
Li Derun patents
Li Derun is listed as an inventor on 58 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Li Derun |
| Total patents | 58 |
| First publication | Jul 7, 2015 |
| Latest publication | Mar 10, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes
US-12440496-B2 · Oct 14, 2025 · US
Systems and methods for diffractive coherent laser combining
US-12332509-B2 · Jun 17, 2025 · US
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
US-12319671-B2 · Jun 3, 2025 · US
Adenosine receptor antagonists, pharmaceutical compositions and their use thereof
US-2025171447-A1 · May 29, 2025 · US
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
US-12275729-B2 · Apr 15, 2025 · US
Arginase inhibitors and methods of use
US-12240867-B2 · Mar 4, 2025 · US
Arginase inhibitors and methods of use
US-12215116-B2 · Feb 4, 2025 · US
Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors
US-12065438-B2 · Aug 20, 2024 · US
Machine-learning based stabilization controller that can learn on an unstable system
US-2024256868-A1 · Aug 1, 2024 · US
Recent patents
Latest publications not already listed above.
Il4i1 inhibitors and methods of use
US-2024246937-A1 · Jul 25, 2024 · US
N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
US-12030872-B2 · Jul 9, 2024 · US
2-aminoquinazolines as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
US-2023303540-A1 · Sep 28, 2023 · US
Arginase inhibitors and methods of use
US-2023140132-A1 · May 4, 2023 · US
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
US-11498904-B2 · Nov 15, 2022 · US
Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes
US-2022281886-A1 · Sep 8, 2022 · US
Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes
US-2022273669-A1 · Sep 1, 2022 · US
1-pyrazolyl, 5-, 6- disubstituted indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
US-2022259188-A1 · Aug 18, 2022 · US
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
US-11319283-B2 · May 3, 2022 · US
Arginase inhibitors and methods of use
US-11274111-B2 · Mar 15, 2022 · US
Arginase inhibitors and methods of use
US-2022056051-A1 · Feb 24, 2022 · US
Novel substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors
US-2021403469-A1 · Dec 30, 2021 · US
Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
US-11208407-B2 · Dec 28, 2021 · US
N-heteroaryl indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
US-2021395236-A1 · Dec 23, 2021 · US
Systems and methods for diffractive coherent laser combining
US-2021341764-A1 · Nov 4, 2021 · US
Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
US-2021317091-A1 · Oct 14, 2021 · US
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
US-11111232-B2 · Sep 7, 2021 · US
Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
US-2021179607-A1 · Jun 17, 2021 · US
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
US-11034661-B2 · Jun 15, 2021 · US
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
US-11028092-B2 · Jun 8, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merck Sharp & Dohme | 40 |
| Merck Sharp & Dohme Llc | 13 |
| Li Derun | 12 |
| Zhang Hongjun | 5 |
| Han Yongxin | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 29 |
| C07D471/04 | 18 |
| C07D487/04 | 18 |
| A61K45/06 | 17 |
| C07D413/14 | 14 |